← Back

Domain Overview: bioneer.dk

Domain Information

FieldValue
ID 122534
Domain bioneer.dk
Title
Meta Description
Headings
Structured Data
[]
Internal Link(s)
External Link(s)
Found In inano.au.dk
HTTP Status 0
IP Address 185.21.41.218
Response Time 0.0
Server Header
Page Load Speed 0.0
Favicon URL
WHOIS Status Active
Created Date 17. december 2003
Registrant Name BIONEER A/S
Registrant Address Kogle Alle 2
Registrant City 2970 Hørsholm
Registrant Country Danmark
Registrant Phone +45 45 16 04 44
Registrar None
Nameservers ["ns01.one.com", "ns02.one.com"]
Registered 2003-12-17
Expires 2025-12-31
Crawl Timestamp 2025-07-26 11:10:33

Inbound Links (Total: 10)

IDSource DomainSource PageLink URLDiscovered AtLast Active
1971746campusudvikling.dtu.dkView Page2025-04-06 16:40:252025-04-06 16:40:25
1065664earlystage.dkView Page2025-02-23 10:57:372025-02-23 10:57:37
2283981euraxess.dkView Page2025-04-25 00:45:042025-04-25 00:45:04
2034331inano.dkView Page2025-04-10 03:29:492025-04-10 03:29:49
8930173inano.dkView Page2025-06-27 16:46:492025-06-27 16:46:49
745102stemscreen.ku.dkView Page2025-02-17 15:26:472025-03-09 18:52:36
6738086teknologiskinfrastruktur.dkView Page2025-06-08 14:13:002025-06-08 14:13:00
6738123teknologiskinfrastruktur.dkView Page2025-06-08 14:13:47None
6738124teknologiskinfrastruktur.dkView Page2025-06-08 14:13:48None
6738188teknologiskinfrastruktur.dkView Page2025-06-08 14:14:58None

Outbound Links (Total: 0)

IDDestination DomainDestination PageLink URLDiscovered AtLast Active

Historical Snapshots

2025-06-01 2025-05-13 2025-04-30 2025-04-20 2025-04-09

Historical Domain Information

FieldValue
ID 122534
Domain bioneer.dk
Title Bioneer home - Bioneer
Meta Description Transforming scientific advancements into better Life Science solutions for tomorrowInnovative solutions for biotech and pharmaceutical companies.
Headings In VitroModelling Cancer and Immuno-Oncology Immunology CNS Gene Editing and Reprogramming Drug Formulation Dynamic Gastric Model (DGM) Biorelevant in-vitro models CellularBarrier Models Peptides& Proteins Small Molecules Recombinant Proteins:         R&D Services Recombinant Proteins– Microbial Recombinant Proteins– Mammalian Recombinant Proteins: Manufacturing Process Development GMP Manufacturing– Microbial Non-GMP Manufacturing– Microbial/Mammalian Cell Models & Assay Development CNS Modelling & Assay Development Cancer Modelling & Assays Gene Editing & Immune models Drug Candidate Development& Formulation Recombinant Protein Expression Protein Refolding Formulation Development Strategic R&DCollaborations Our Company Locations Leadership GTS Latest news Meet us at Latest publications In the press Working at Bioneer Open positions Meet our team In VitroModelling Cancer and Immuno-Oncology Immunology CNS Gene Editing and Reprogramming Drug Formulation Dynamic Gastric Model (DGM) Biorelevant in-vitro models CellularBarrier Models Peptides& Proteins Small Molecules Recombinant Proteins:         R&D Services Recombinant Proteins– Microbial Recombinant Proteins– Mammalian Recombinant Proteins: Manufacturing Process Development GMP Manufacturing– Microbial Non-GMP Manufacturing– Microbial/Mammalian Cell Models & Assay Development CNS Modelling & Assay Development Cancer Modelling & Assays Gene Editing & Immune models Drug Candidate Development& Formulation Recombinant Protein Expression Protein Refolding Formulation Development Strategic R&DCollaborations Our Company Locations Leadership GTS Latest news Meet us at Latest publications In the press Working at Bioneer Open positions Meet our team Transforming scientific advancements into better Life Science solutionsfor tomorrow CONTACT INFORMATION GET IN TOUCH Latest news Now available: High-density MEA assay service for advanced neuronal research A product for one of the most common childhood cancers Chief CDMO Officer for Bioneer´s small scale CDMO business unit Senior Business Development Manager – In Vitro Modelling Advancing Stem Cell Therapies – From Research to Reality
Structured Data
["{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https://bioneer.dk/\",\"url\":\"https://bioneer.dk/\",\"name\":\"Bioneer home - Bioneer\",\"isPartOf\":{\"@id\":\"https://bioneer.dk/#website\"},\"datePublished\":\"2015-12-14T04:09:47+00:00\",\"dateModified\":\"2025-03-21T13:04:05+00:00\",\"description\":\"Transforming scientific advancements into better Life Science solutions for tomorrowInnovative solutions for biotech and pharmaceutical companies.\",\"breadcrumb\":{\"@id\":\"https://bioneer.dk/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https://bioneer.dk/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https://bioneer.dk/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https://bioneer.dk/#website\",\"url\":\"https://bioneer.dk/\",\"name\":\"Bioneer\",\"description\":\"your trusted life science partner\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https://bioneer.dk/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}"]
Internal Link(s) ["http://bioneer.dk#content", "https://bioneer.dk/", "https://bioneer.dk/our-services/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-rd-programs/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/about/", "https://bioneer.dk/about/#company", "https://bioneer.dk/about/#locations", "https://bioneer.dk/about/#leadership", "https://bioneer.dk/about/#gts", "https://bioneer.dk/bioneer/about/#company", "https://bioneer.dk/bioneer/about/#locations", "https://bioneer.dk/bioneer/about/#leadership", "https://bioneer.dk/bioneer/about/#gts", "https://bioneer.dk/news/", "https://bioneer.dk/news/", "https://bioneer.dk/news/#meet", "https://bioneer.dk/news/#publications", "https://bioneer.dk/news/#press", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/#meet", "https://bioneer.dk/bioneer/news/#publications", "https://bioneer.dk/bioneer/news/#press", "https://bioneer.dk/careers/", "https://bioneer.dk/careers/#workingatbioneer", "https://bioneer.dk/careers/#positions", "https://bioneer.dk/careers/#team", "http://bioneer.dk/bioneer/careers/#workingatbioneer", "http://bioneer.dk/bioneer/careers/#positions", "http://bioneer.dk/bioneer/careers/#team", "https://bioneer.dk/bioneer/partners/", "https://bioneer.dk/contact/", "https://bioneer.dk/", "https://bioneer.dk/our-services/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-rd-programs/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/about/", "https://bioneer.dk/about/#company", "https://bioneer.dk/about/#locations", "https://bioneer.dk/about/#leadership", "https://bioneer.dk/about/#gts", "https://bioneer.dk/bioneer/about/#company", "https://bioneer.dk/bioneer/about/#locations", "https://bioneer.dk/bioneer/about/#leadership", "https://bioneer.dk/bioneer/about/#gts", "https://bioneer.dk/news/", "https://bioneer.dk/news/", "https://bioneer.dk/news/#meet", "https://bioneer.dk/news/#publications", "https://bioneer.dk/news/#press", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/#meet", "https://bioneer.dk/bioneer/news/#publications", "https://bioneer.dk/bioneer/news/#press", "https://bioneer.dk/careers/", "https://bioneer.dk/careers/#workingatbioneer", "https://bioneer.dk/careers/#positions", "https://bioneer.dk/careers/#team", "http://bioneer.dk/bioneer/careers/#workingatbioneer", "http://bioneer.dk/bioneer/careers/#positions", "http://bioneer.dk/bioneer/careers/#team", "https://bioneer.dk/bioneer/partners/", "https://bioneer.dk/contact/", "https://bioneer.dk/author/admin/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/drug-formulation", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/wp-content/uploads/2025/03/Mea-multielectrode-array-illustration.png", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/wp-content/uploads/2025/03/Ymabs-and-Bioneer.webp", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/wp-content/uploads/2025/04/jobposting-CDMO.jpg", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/wp-content/uploads/2023/12/DSC_1918-scaled-e1701955212348.jpg", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/event/advancing-stem-cell-therapies-from-research-to-reality/", "https://bioneer.dk/event/advancing-stem-cell-therapies-from-research-to-reality/", "https://bioneer.dk/bioneer/privacy-policy/", "https://bioneer.dk/bioneer/newsletter/", "https://bioneer.dk/index.php/privacy-policy/", "http://bioneer.dk", "http://bioneer.dk"]
External Link(s) ["https://www.linkedin.com/company/bioneer/"]
Found In -
HTTP Status 200
IP Address 185.21.41.218
Response Time 2.85804
Server Header LiteSpeed
Page Load Speed 2.85804
Favicon URL https://bioneer.dk/wp-content/uploads/2021/06/Favicon1.png
WHOIS Status Active
Created Date 17. december 2003
Registrant Name BIONEER A/S
Registrant Address Kogle Alle 2
Registrant City 2970 Hørsholm
Registrant Country Danmark
Registrant Phone +45 45 16 04 44
Registrar None
Nameservers ["ns01.one.com", "ns02.one.com"]
Registered 2003-12-17
Expires 2025-12-31
Crawl Timestamp 2025-04-09 21:06:22